Artivion | CRY - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 6.8B 1.72B 2026-03
Accuray USD 41.29M 22.05M 2025-12
AngioDynamics USD 41.64M 14.26M 2025-09
Artivion USD 77.32M 21.55M 2026-06
AtriCure USD 167.79M 21.62M 2026-06
Baxter International USD 2.15B 133M 2026-06
Becton, Dickinson and Co. USD 708M 105M 2026-06
Boston Scientific USD 539M 914M 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
Inogen USD 106.48M 2.79M 2025-09
Integra LifeSciences USD 214.42M 22.39M 2026-06
J&J USD 20.42B 1.27B 2026-06
Mesa Laboratories USD 28.98M 8.55M 2025-12
Orthofix International USD 103.81M 16.47M 2026-06
Pfizer USD 976M 727M 2026-06
ResMed USD 1.47B 191.28M 2026-06
Stryker USD 3.39B 513M 2026-06
Tandem Diabetes Care USD 62.82M 116.51M 2026-06
Teleflex USD 300.16M 9.25M 2026-06
Terumo JPY 280.49B 63.34B 2026-03
Trinity Biotech USD 5.14M 3.8M 2025-12